Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
40 Cards in this Set
- Front
- Back
What suffix generally indicated a benign tumor?
|
-oma
|
|
Describe benign tumors of epithelial origin
|
1. Arise from ectoderm or endoderm
2. Example: tubular adenoma (adenomatous polyp) arising from gland in the colon |
|
Describe benign tumors of connective tissue origin
|
1. Arise from mesoderm
2. Examples- lipoma from adipose |
|
What types of tumors are usually benign?
|
-Mixed tumors
-Teratomas |
|
Describe mixed tumors
|
1. Neoplastic cells have two different morphologic patterns but derive from the same germ cell layer
2. Example: pleomorphic adenoma of the parotid gland |
|
Describe teratomas
|
1. Tumors that derive from more than one germ cell layer
-Contain tissue derived from ectoderm, endoderm, and mesoderm 2. Sites -Ovaries, testes, anterior mediastinum, and pineal gland |
|
Describe carcinomas
|
1. Malignant tumors
2. Derive from epithelial tissue- squamous, glandular, transitional |
|
Describe the sites of squamous cell carcinoma
|
1. Oropharynx
2. Larynx 3. Upper/middle esophagus 4. Lung 5. Cervix 6. Skin |
|
Describe the sites of adenocarcinoma (glandular epithelium)
|
1. Lung
2. Distal esophagus to rectum 3. Pancreas 4. Liver 5. Breast 6. Endometrium 7. Ovaries 8. Kidneys 9. Prostate |
|
Describe the sites of transitional cell carcinoma
|
1. Urinary bladder
2. Ureter 3. Renal pelvis |
|
Describe sarcomas
|
1. Malignant tumors
2. Derive from connective tissue 3. Examples: osteogenic sarcoma in bone |
|
What are tumor-like conditions?
|
-Hamartoma
-Choristoma (heterotopic rest) |
|
Describe Hamartomas
|
1. Non-neoplastic overgrowth of disorganized tissue indigenous to a particular site
2. Examples: Bronchial hamartoma (contains cartilage), Peutz-Jeghers polyp |
|
Describe Choristomas (heterotopic rest)
|
1. Non-neoplastic normal tissue in a foreign location
2. Examples: panceatic tissue in the stomach wall; parietal cells in Meckel diverticulum |
|
Describe the components of benign and malignant tumors
|
1. Parenchyma
-Neoplastic component that determines the tumor's biologic behavior 2. Stroma a. Non-neoplastic supportive tissue b. Most infiltrating carcinomas induce production of a dense, fibrous stroma |
|
Describe the differentiation of benign tumors
|
Usually well differentiated (resemble parent tissue)
|
|
Describe the differentiation of malignant tumors
|
1. Well differentiated or low grade
a. Resemble parent tissue b. Examples: produce keratin pearls or glandular lumens with secretions 2. Poorly differentiated, high grade, or anaplastic -No distinguishing features 3. Intermediate Grade -Features are between low and high grade cancer |
|
Describe the nuclear features of benign tumors
|
1. Nuclear/cytoplasmic ratio is close to normal
2. Mitoses have normal mitotic spindles |
|
Describe the nuclear features of malignant tumors
|
1. Nuclear/cytoplasmic ration is increased and nucleoli are prominent
2. Mitoses have normal and atypical mitotic spindles |
|
Describe the growth rate of benign tumors
|
Usually have a slow growth rate
|
|
Describe the growth rate of malignant tumors
|
-Have a variable growth rate
a. Correlates with the degree of differenttiation b. Anaplastic (high-grade) cancers have an increased growth rate |
|
When does a tumor become clinically evident?
|
Thirty doubling times are required for a tumor to be clinically evident
-Equivalent to 10^9 cells, 1 g of tissue, volume of 1 L |
|
Describe the types of neoplastic cells that are targeted by chemotherapy
|
-Malignant cells in the cell cycle are primarily targeted by chemotherapy
1. DNA is exposed an is susceptible to damage by drugs and radiation causing the cells to die 2. Loss of the cells causes more cancer cells to go into the cell cycle; hence debulking the tumor as these cells also get destroyed |
|
Describe the monoclonality of neoplasms
|
1. Benign and malignant tumors derive from a single precursor cell
2. Non-neoplastic proliferations derive from multiple cells (polyclonal) |
|
Describe the monoclonal origin of neoplasms
|
-Have been shown by studying glucose-6-phosphate dehydrogenase (G6PD) isoenzymes A and B in selected neoplasms(eg leiomyoma of the uterus)
-All the neoplastic smooth muscle cells in uterine leiomyomas have either the A or the B G6PD isoenzyme -Non-neoplastic smooth muscle proliferations in the uterus (eg pregnant uterus) have some cells with the A isoenzyme and others with the B isoenzyme, indicating their polyclonal origin |
|
Describe telomerase activity in neoplasms
|
1. Telomerase
a. Preserves length of telomeres -Sequences of nontranscribed DNA at the ends of chromosomes b. Prevent gene loss after multiple cell divisions 2. Benign tumors have normal telomerase activity 3. Malignant tumors have upregulation of telomerase activity -They do not lose genetic material after multiple cell divisions |
|
Describe local ingestion
|
1. Benign tumors
a. They do not invade b. They are usually enclosed by a fibrous capsule -Exception- uterine leiomyomas do not have a fibrous tissue capsule 2. Malignant tumors invade tumors 3. Some tissues resist invasion -Examples: mature cartilage, elastic tissue in arteries |
|
Give examples of tissues that are resistant to invasion
|
Mature cartilage, elastic tissues in arteries
|
|
Describe the sequence of invasion by malignant tumors
|
1. Loss of intercellular adherence
-E-cadherin (intercellular adhesion agent) is not produced 2. Cell invasion occurs a. Cell receptors attach to laminin (glycoprotein in the basement membrane) b. Cells release type IV collagenase (metalloproteinase containing zinc) -Dissolves the basement membrane c. Cell receptors attach to fibronectin in the extracellular matrix d. Cells produce cytokines (stimulate locomotion) and proteases (dissolve connective tissue) e. Cells produce factors that stimulate angiogenesis -Secrete vascular endothelial growth factor and basic fibroblast growth factor |
|
Describe what tumors metastasize
|
1. Benign tumors do not metastasize
2. Malignant tumors metastasize |
|
Describe the pathways of dissemination
|
1. Lymphatic spread to lymph nodes
2. Hematogenous spread 3. Seeding |
|
Describe the lymphatic spread of metastasis to lymph nodes
|
Usual mechanism of dissemination of carcinomas
|
|
Describe the hematogenous of metastasis
|
1. Usual mechanism of dissemination for sarcomas
2. Cells entering the portal vein metastasize to the liver 3. Cells entering the vena cava metastasize to the lungs |
|
Describe seeding dissemination of metastasis
|
-Malignant cells exfoliate from a surface and implant and invade tissue in a body cavity
1. Primary surface-derived ovarian cancers (eg, serous cystadenocarcinoma) commonly seed the omentum 2. Peripherally located lung cancers commonly seed the parietal and visceral pleurae 3. Glioblastoma multiforme commonly seeds the CSF causing spread to the brain and spinal cord |
|
Describe bone metastasis to the vertebral column
|
1. Most common metastatic site in bone
2. Due to the Batson paravertebral venous plexus -It has connections with the vena cava and the vertebral bodies |
|
Describe osteoblastic metastases
|
1. Increased serum alkaline phosphatase indicated reactive bone formation
2. Radiodensities are seen on radiographs |
|
Describe osteolytic metastases
|
1. Radiolucencies are seen on radiographs (eg lung cancer)
2. Potential consequences of osteolytic metastases a. Pathologic fractures b. Hypercalcemia |
|
Describe the pathogenesis of osteolytic metastases
|
1. Tumor may produce substances that locally activate osteoclasts producing lytic lesions
-Example: PGE2, IL-1 2. Tumor produces parathyroid hormone (PTH)- related protein; no lytic lesions due to generalized increase in osteoclast activity -Examples: Squamous cell carcinoma in the lung, renal cell carcinoma |
|
How is pain in bone metastasis treated?
|
Local radiation therapy
|
|
Where is metastasis more common than primary cancer?
|
1. Lymph nodes (eg metastatic breast and lung cancer)
2. Lungs (eg metastatic breast cancer) 3. Liver (eg metastatic lung cancer) 4. Bone (eg metastatic breast cancer) 5. Brain (eg metastatic lung cancer) |